Pharma job market pulse DACH: what the hiring data says this month
Pharma-related job postings in Germany are holding up better than the market as a whole. Indeed’s index for scientific research and development roles stood at 88.9 on 6th November 2026, 7.2% below a year earlier, while all German postings fell 9.0%. Chemical engineering postings are back at last year’s level after rising 6.1% in four weeks. The company news reads differently: in 2026 so far I’ve logged 10 restructuring announcements and 3 investment pull-backs at DACH sites, against 8 new or confirmed investments, most of them at contract manufacturers.
Updated on 14th November 2026. Indeed data up to 6th November 2026. Next update planned for 7th December 2026. Compiled by Andreas Schulz, MoreThanCareer.de.
This month in eight numbers
- 88.9Indeed job postings index, Germany: Scientific research and development−7.2% on a year earlier+2.2% in four weeks
- 107.5Indeed job postings index, Germany: Chemical engineering+0.2% on a year earlier+6.1% in four weeks
- 135.8Indeed job postings index, Germany: Production and manufacturing+1.3% on a year earlier+2.6% in four weeks
- 104.8Indeed job postings index, Germany: All job postings in Germany−9.0% on a year earlier+2.5% in four weeks
- 654,000Vacancies registered with the German Federal Employment Agency, October 2026 [2]+31,000 on a year earlier
- 40,462Vacancies registered at Swiss RAV offices, October 2026 [14]+15.6% on a year earlier
- 73,733Immediately available vacancies at Austria’s AMS, October 2026 [19]−3.4% on a year earlier
- −5.9ifo business climate, German chemical industry, October 2026 [6]from +3.0 in September
My read this month
- Manufacturing jobs are moving between sites. Old capacity is closing: COVID vaccine lines at BioNTech, small-volume biologics at Novartis in Basel, a production site in Wehr. New capacity goes to contract manufacturers and newer drug types, such as Vetter’s injectables plant in Saarlouis and Bachem’s peptide and oligonucleotide building in Bubendorf. Indeed’s production and manufacturing postings are 1.3% above last year, which fits that picture.
- Germany’s health cost-cutting law, then still a bill, gave three large employers a public reason to pull back: Eli Lilly halved the rest of its Alzey project, Boehringer Ingelheim stopped €900 million of 2027 to 2030 spending and Pfizer put its German plans under review. Those decisions are about capacity a few years out. I think the hiring effect will show up in 2027 and 2028 job ads, not in this autumn’s figures.
- Switzerland’s official vacancy figures rose year on year, by 15.6% at the regional employment centres and 2.7% in the federal survey, while several pharma and MedTech sites announced cuts. Part of the RAV jump probably comes from the wider job registration duty: 63.8% of October’s registered vacancies fell under it, against 53.8% a year earlier.
These are my interpretations. The figures they rest on are in the tables below, each with its source.
Job postings in Germany by occupation
Indeed Hiring Lab publishes a daily index of job postings on Indeed in Germany, by occupation. A value of 100 equals the level on 1st February 2020, so 90 means 10% fewer postings than then. The series are seasonally adjusted, 7-day averages. Latest value: 6th November 2026. Indeed’s "Pharmacy" group covers pharmacists and pharmacy technicians, most of them in community and hospital pharmacies, so it says less about the pharma industry than the first three rows.
| Occupation group | Index now | 1 week ago | 4 weeks ago | 13 weeks ago | 52 weeks ago | Change on a year |
|---|---|---|---|---|---|---|
| All job postings in Germany | 104.8 | 105.1 | 102.3 | 103.1 | 115.2 | −9.0% |
| Scientific research and development | 88.9 | 89.0 | 87.0 | 88.0 | 95.9 | −7.2% |
| Chemical engineering | 107.5 | 110.1 | 101.4 | 93.9 | 107.3 | +0.2% |
| Production and manufacturing | 135.8 | 135.3 | 132.4 | 130.1 | 134.1 | +1.3% |
| Pharmacy (pharmacists and pharmacy technicians) | 112.0 | 115.1 | 106.8 | 117.3 | 119.0 | −5.9% |
| Industrial engineering | 69.9 | 70.1 | 67.7 | 67.4 | 70.5 | −0.9% |
| Mechanical engineering | 105.3 | 105.1 | 103.0 | 97.5 | 101.1 | +4.2% |
| Data and analytics | 74.0 | 73.7 | 73.2 | 76.2 | 85.6 | −13.5% |
| Software development | 48.6 | 48.8 | 47.6 | 50.6 | 57.2 | −15.1% |
| Project management | 81.5 | 81.9 | 80.2 | 81.9 | 87.1 | −6.5% |
| Marketing | 62.9 | 63.4 | 63.8 | 62.3 | 74.1 | −15.1% |
| Sales | 93.4 | 92.2 | 90.0 | 87.9 | 104.7 | −10.9% |
| Human resources | 79.2 | 79.6 | 78.8 | 82.5 | 84.5 | −6.3% |
| Management | 107.3 | 107.5 | 106.2 | 106.0 | 114.2 | −6.1% |
Rows in bold have a direct link to pharma, biotech and MedTech hiring.
All job postings by German state
Indeed publishes the regional series for all occupations together, not by occupation. States marked with a dot have large pharma or biotech clusters.
| State | Index now | 52 weeks ago | Change on a year |
|---|---|---|---|
| Baden-Württemberg • | 101.4 | 112.8 | −10.1% |
| Bavaria • | 98.3 | 109.3 | −10.1% |
| Berlin • | 74.1 | 78.5 | −5.7% |
| Brandenburg | 119.0 | 128.0 | −7.0% |
| Bremen | 103.3 | 107.6 | −4.0% |
| Hamburg | 82.2 | 90.5 | −9.2% |
| Hesse • | 100.9 | 113.1 | −10.8% |
| Lower Saxony | 132.3 | 142.5 | −7.1% |
| Mecklenburg-Western Pomerania | 122.7 | 135.1 | −9.2% |
| North Rhine-Westphalia • | 118.0 | 132.5 | −10.9% |
| Rhineland-Palatinate • | 117.7 | 127.3 | −7.6% |
| Saarland | 135.0 | 138.4 | −2.4% |
| Saxony | 99.5 | 109.7 | −9.3% |
| Saxony-Anhalt | 125.8 | 131.5 | −4.3% |
| Schleswig-Holstein | 131.8 | 143.3 | −8.0% |
| Thuringia | 115.4 | 131.7 | −12.4% |
Official and industry data
The latest figure from each source, as its publisher states it. Most of these are monthly or quarterly, so they change less often than the Indeed series.
Germany
| # | What it measures | Source | Published |
|---|---|---|---|
| 1 | Registered unemployed, October 2026: 2,955,000, rate 6.3%, up 44,000 on a year earlier | Bundesagentur für Arbeit, Arbeitsmarkt im Oktober 2026, Presseinfo Nr. 41 | 30th October 2026 |
| 2 | Registered vacancies, October 2026: 654,000, up 31,000 on a year earlier | Bundesagentur für Arbeit, Arbeitsmarkt im Oktober 2026, Presseinfo Nr. 41 | 30th October 2026 |
| 3 | BA-X job index, October 2026: 102 points, down 1 on the month, up 4 on the year | Bundesagentur für Arbeit, Arbeitsmarkt im Oktober 2026, Presseinfo Nr. 41 | 30th October 2026 |
| 4 | Jobs subject to social insurance, August 2026: 34.87 million, down 45,000 on a year earlier | Bundesagentur für Arbeit, Arbeitsmarkt im Oktober 2026, Presseinfo Nr. 41 | 30th October 2026 |
| 5 | ifo employment barometer, October 2026: 95.5 points, after 95.1 in September; industry plans slightly worse than in September | ifo Institut, Unternehmen wollen weniger Stellen abbauen (Oktober 2026) | 28th October 2026 |
| 6 | ifo business climate, chemical industry, October 2026: −5.9 points, after +3.0 in September; expectations −13.8; capacity use 76.6% | Handelsblatt (Reuters), reporting ifo Institut, Umfrage: Ifo-Geschäftsklima in der Chemie verschlechtert sich | 3rd November 2026 |
| 7 | Hays skilled-worker index, Q3 2026: 39%, up from 36%; life sciences down 1 point; quality managers up 14 points | Hays AG, Hays Fachkräfte-Index Q3/2026 | 3rd November 2026 |
| 8 | Pharma production, Q2 2026: +1.3% on the quarter and +1.3% on the year; chemical and pharma employment 466,736, about 2% below a year earlier | Verband der Chemischen Industrie (VCI), Quartalsbericht 2/2026 | 3rd September 2026 |
| 9 | VCI forecast for 2026: chemical and pharma production −1.5%, producer prices about +4%, sales +2.5% | Verband der Chemischen Industrie (VCI), Quartalsbericht 2/2026 | 3rd September 2026 |
| 10 | German pharma industry, 2025: 134,200 employees, sales €61.9 billion, 63% abroad | Verband der Chemischen Industrie (VCI), Branchenporträt 2026 | 2026 |
| 11 | vfa member companies employ about 100,000 people in Germany, about 20,000 of them in R&D | vfa, Pressemitteilung Nr. 30/2026 | 26th August 2026 |
| 12 | Pharmacists, 2025: about 1,000 vacancies reported to the BA (+7%), unemployed pharmacists +10%, just over 8,000 pharmacists in the pharma industry | Pharmazeutische Zeitung, reporting BA and ABDA data, 10 Prozent mehr arbeitslose Pharmazeuten | 17th July 2026 |
| 13 | GKV-Beitragssatzstabilisierungsgesetz passed: the general manufacturer rebate on medicines rises from 7% to 15.5% | Deutscher Bundestag, Nach hitziger Debatte: Bundestag verabschiedet GKV-Finanzreform | 10th July 2026 |
Switzerland
| # | What it measures | Source | Published |
|---|---|---|---|
| 14 | October 2026: 141,015 registered unemployed, rate 3.0%, +4.3% on the year; 40,462 vacancies at RAV offices, +15.6% on the year, 63.8% subject to the registration duty | SECO, Die Lage auf dem Arbeitsmarkt im Oktober 2026 | 5th November 2026 |
| 15 | October 2025: 34,995 vacancies at RAV offices, 53.8% subject to the registration duty | SECO, Die Lage auf dem Arbeitsmarkt im Oktober 2025 | November 2025 |
| 16 | Q2 2026: 98,700 vacancies, +2.7% on the year (industry and construction +21.8%, services −2.4%); employment +2.0% | Bundesamt für Statistik (BFS), Beschäftigungsstatistik, 2. Quartal 2026 | 27th August 2026 |
| 17 | Job postings, Q3 2026: +0.8% on the quarter and +0.8% on the year | Adecco Group and University of Zurich (Swiss Job Market Monitor), Swiss Job Market Index Q3 2026 | 15th October 2026 |
| 18 | US Section 232 tariffs on pharmaceutical products apply from 31 July 2026, with an additional duty of up to 15% on imports from Switzerland | SECO, Swiss-US trade relations | from 31 July 2026 |
Austria
| # | What it measures | Source | Published |
|---|---|---|---|
| 19 | October 2026: 314,499 registered unemployed (+1.3%), national rate 7.3%; 73,733 immediately available vacancies (−3.4%) | news.at, reporting AMS data, Arbeitslosigkeit Oktober 2026: Österreich und Bundesländer | 2nd November 2026 |
| 20 | Clinical trials in Austria generate €174 million of gross value added a year and secure over 2,200 jobs; the number of trials is falling | Pharmig, Klinische Forschung als Wachstumsmotor | 9th July 2026 |
Employer moves at DACH sites in 2026
Announcements I’ve logged from public reports this year. Cuts or closures: 10; investments cut or under review: 3; investments: 8; hiring or training intakes: 1; reorganisations without announced job cuts: 1. Job figures are as reported; "worldwide" means the German, Swiss or Austrian share wasn’t given.
| Date | Employer and site | Type | Jobs | What was announced | Source |
|---|---|---|---|---|---|
| 05/11/2026 | Siemens Healthineers, group-wide (Germany) | Cuts or closure | no figure given | New savings programme with full-year results; cross-company functions such as service, marketing and controlling under review | MS Aktuell |
| 12/10/2026 | Zimmer Biomet, Winterthur (Switzerland) | Cuts or closure | up to 490, down from up to 580 first announced | MedTech plant restructuring after consultation; no jobs to go before 2028, phased to 2030 | AWP via cash.ch |
| 21/09/2026 | Roche, Basel (Switzerland) | Investment | not stated | Ground broken for a CHF 790 million facility for synthetic active ingredients; CHF 1.4 billion of building projects under way at Basel and Kaiseraugst | Switzerland Global Enterprise |
| 02/09/2026 | Novartis, Basel (Kleinbasel) (Switzerland) | Cuts or closure | up to 130 | Small-volume biologics production to end by the end of 2027; labs move to the Novartis Campus by the end of 2028 | SRF |
| 01/09/2026 | Bayer, Wuppertal and Bergkamen (Germany) | Hiring or training intake | 57 apprentices and 16 pre-apprenticeship places in Wuppertal; 38 apprentices in Bergkamen | Training intake at two pharma sites, including chemistry, biology and production occupations | Bayer press releases |
| 29/07/2026 | Bayer, Bergkamen (Germany) | Reorganisation | none announced (about 1,650 work at the Bergkamen supply center, including a Berlin site) | Separate operating company for site infrastructure and services, planned for 2027; Bayer wants to develop the site into a pharma and chemical park. About €50 million was invested in Bergkamen in 2025 | Bayer press release |
| 16/07/2026 | Merck, Darmstadt (Germany) | Investment | not stated | New €25 million testing centre for releasing medicines opened | Deutsches Ärzteblatt |
| 15/07/2026 | Siemens Healthineers, Kemnath (Germany) | Investment | not stated | €70 million for a new production hall for MedTech components | Siemens Healthineers press release |
| 16/06/2026 | Siegfried, Minden (Germany) | Investment | not stated | New large-scale API production plant opened, reactor capacity up by 100 m³ | CHEManager |
| 10/06/2026 | Pfizer, German sites (Germany) | Investment cut or review | not stated (more than 3,000 employees in Germany) | Timing, scope and priority of planned German investments under review | Reuters via onvista |
| 10/06/2026 | Roche, Penzberg (Germany) | Investment | not stated | Keeps the €600 million diagnostics production site, completion expected by 2027; future German investments under careful review | Reuters via Medical Dialogues |
| 03/06/2026 | Eli Lilly, Alzey (Germany) | Investment cut or review | about 300 already hired; plan was up to 1,000 | Remaining scope of the plant cut by 50%, citing German health policy | dpa International via Newswav |
| 03/06/2026 | Boehringer Ingelheim, German sites (Germany) | Investment cut or review | not stated | €900 million of planned 2027 to 2030 investment stopped, including new lab buildings | Pharmazeutische Zeitung |
| 14/05/2026 | Takeda, Opfikon (Switzerland) | Cuts or closure | up to 280 of about 1,100 | Part of a global transformation programme; the company says new roles will also be created | AWP via Südostschweiz |
| 12/05/2026 | Carl Zeiss Meditec, Jena and group-wide (Germany) | Cuts or closure | up to 1,000 worldwide, later put at 600 to 700 net | MedTech savings programme ProfitUp; the German share has not been stated | Deutsches Ärzteblatt (dpa) |
| 05/05/2026 | BioNTech, Marburg, Idar-Oberstein, Tübingen (Germany) | Cuts or closure | up to 1,860, including Singapore | Closure of the German production sites by the end of 2027; office sites stay | Handelsblatt |
| 05/05/2026 | Novartis, Wehr (Germany) | Cuts or closure | about 220 | Production site to close by the end of 2028 | Keystone-SDA via blue News |
| 24/04/2026 | Bachem, Bubendorf (Switzerland) | Investment | not stated | Building K opened for large-scale peptide and oligonucleotide production | AWP via VZ VermögensZentrum |
| 13/03/2026 | Sandoz, Kundl (Austria) | Cuts or closure | around 100 (works council: 170 to 190) | Development centre affected; antibiotics production not affected | Keystone-SDA via blue News; works council figure via stol.it |
| 11/03/2026 | Evotec, Hamburg and group-wide (Germany) | Cuts or closure | up to 800 worldwide | Restructuring programme Horizon; the German share was not stated | Deutsches Ärzteblatt (dpa) |
| 19/02/2026 | Roche, Kaiseraugst (Switzerland) | Cuts or closure | about 100 staff in production | Production of the antibiotic Rocephin to end by the end of the decade; Roche is looking for a buyer | AWP via cash.ch |
| 29/01/2026 | Vetter, Saarlouis (Germany) | Investment | 400 to 500 at first, up to 2,000 long term | New injectables plant, about €480 million for phase one; building work started in May 2026, operations planned for 2031 | dpa-AFX via Börse Online |
| 27/01/2026 | Complex Pharmaceuticals, Traiskirchen (Austria) | Investment | more than 60 by 2028 | New contract manufacturing plant, production planned from early 2027 | Weekend.at |
Why I track this
A slow job search raises one question before all others: is it me or the market? This page answers the market half with numbers, once a month, and every number links to the place it came from. I’ve worked in recruitment for 17 years, 14 of them in pharma and CRO environments, and I’d rather show the data than describe a mood.
Related: DACH pharma salary bands and Job search statistics, fact-checked.
Methodology
- Indeed series: downloaded fresh for every monthly edition from the Indeed Hiring Lab data repository on GitHub and shown as published. Indeed covers postings on its own site, so roles advertised only on company career pages, LinkedIn or StepStone are missing unless Indeed also lists them. The 4-week and 1-year changes are my own calculation from Indeed’s published values.
- Indeed publishes occupation and regional series for Germany. It doesn’t publish them for Switzerland or Austria, so those two countries rely on official statistics and the Adecco Group Swiss Job Market Index.
- Official data points: the most recent release of each source at the time of the update. When a source publishes a new figure, it replaces the old one and the changelog says so.
- Employer moves: announcements about sites in Germany, Switzerland and Austria from pharma, biotech, CDMO and MedTech companies, taken from company statements and news agencies. A company figure that wasn’t confirmed is marked as reported.
- Interpretation: the section "My read this month" is my opinion. Everything else is data with a named source.
- Not included: salaries (see the salary bands hub) and any data that sits behind a login or a paywall.
Changelog
- 14th November 2026: First edition: Indeed postings for 13 occupation groups and 16 German states, 20 official and industry data points for Germany, Switzerland and Austria, 23 employer announcements from 2026.
Download, embed and cite
My compilation, the CSV file and the charts are licensed under CC BY 4.0. The Indeed series come from Indeed Hiring Lab, also under CC BY 4.0, and need that credit too. Third-party figures in the other tables belong to their publishers. Download the CSV.
Suggested citation
Schulz, A. (2026). Pharma job market pulse DACH, November 2026. MoreThanCareer.de. https://morethancareer.de/pharma-job-market-pulse-dach.htmlJournalists and researchers: for a comment on the latest figures, write to andreas.schulz@morethancareer.de.
Frequently asked questions
What is the pharma job market pulse DACH?
A monthly page that tracks hiring demand in pharma, biotech and MedTech in Germany, Switzerland and Austria. It combines Indeed job postings data, official labour market statistics, industry surveys and a log of employer announcements, each with its source.
Is the pharma job market in Germany getting better or worse?
On the latest Indeed data (6th November 2026), postings for scientific research and development roles changed by −7.2% on a year earlier and all postings in Germany by −9.0%. Chemical engineering moved by +0.2% and production and manufacturing by +1.3%. The monthly summary at the top of this page puts those numbers in context.
How often is this page updated?
Once a month, in the first week after the German, Swiss and Austrian labour market figures for the previous month come out, so every official number on the page is fresh at the same time. Quarterly sources change when their publishers release new numbers.
Why aren’t Switzerland and Austria in the Indeed chart?
Indeed Hiring Lab publishes occupation-level posting data for Germany but not for Switzerland or Austria. For those countries the page uses SECO, the Swiss Federal Statistical Office, the Adecco Group Swiss Job Market Index and the Austrian AMS.
Can I use the charts and data?
Yes. My compilation and charts are under CC BY 4.0, so you can reuse them with a link to this page. The Indeed series need a credit to Indeed Hiring Lab. Figures from other publishers stay theirs; cite them directly.
Is your search slower than the market?
I spent 17 years in recruitment, 14 of them in pharma and CRO environments at Bayer, ICON and Syneos Health. The first conversation is twenty minutes and costs nothing.
Book a discovery call